GlassScriptPhysician profile
John Vianney Martin
NPI 1912007873
$3,995.65
in general payments reported to CMS, 2019-2025
38 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $596 · 2020: $453 · 2021: $733 · 2022: $695 · 2023: $785 · 2024: $576 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,519.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,069.26 | 2019-2024 | |
| Daiichi Sankyo INC. | $476.38 | 2019-2025 | Injectafer |
| Astellas Pharma US INC | $397.29 | 2022-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $364.39 | 2019-2025 | |
| Exeltis, USA INC. | $299.30 | 2020-2025 | Slynd |
| Mayne Pharma Commercial LLC | $175.32 | 2022-2025 | |
| Intuitive Surgical, INC. | $139.42 | 2020-2021 | |
| Therapeuticsmd, INC. | $120.02 | 2020-2022 | |
| Hologic Sales and Service, LLC | $92.23 | 2021-2025 | Aptima, Thinprep 2000 Processor, Coolseal Generator |
| Novo Nordisk INC | $80.65 | 2022-2023 | Wegovy |
| Roche Diagnostics Corporation | $77.92 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $73.08 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.01 | 2019-2024 | |
| Optumhealth Care Solutions, LLC | $60.88 | 2023-2024 | Vivify Health Care Team Portal, Zyno Solutions, Eitan Medical |
| Evofem Biosciences, INC. | $57.68 | 2021-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $49.00 | 2022 | |
| Sage Therapeutics, LLC | $31.81 | 2024 | |
| Agile Therapeutics, INC. | $28.07 | 2021-2024 | Twirla |
| Amgen INC. | $27.94 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $24.97 | 2019 | |
| Amag Pharmaceuticals, INC. | $24.08 | 2021 | |
| Corcept Therapeutics | $21.95 | 2022 | |
| Becton, Dickinson and Company | $19.61 | 2022 | |
| Duchesnay USA Incorporated | $18.38 | 2019 | |
| Merck Sharp & Dohme LLC | $18.34 | 2023 | Gardasil 9 |
| Pacira Pharmaceuticals Incorporated | $17.78 | 2021 | |
| Gynesonics, INC. | $17.28 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Endo Pharmaceuticals INC. | $15.47 | 2019 | |
| Medicem INC. | $15.15 | 2023 | |
| Avion Pharmaceuticals | $14.89 | 2021 | |
| Sumitomo Pharma America, INC. | $14.51 | 2024 | Myfembree |
| Exact Sciences Corporation | $14.21 | 2023 | Cologuard Collection Kit |
| Nalpropion Pharmaceuticals LLC | $13.86 | 2019 | |
| Biogen, INC. | $13.84 | 2024 | Zurzuvae |
| Allergan, INC. | $13.23 | 2019 | |
| Organon LLC | $12.58 | 2025 | Jada System |
| Lupin INC. | $11.49 | 2020 | |
| Kerecis Limited | $2.38 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.